Increased expression and activity of GSK-3β have also been reported in the skeletal muscle of patients with DM1, which is a complex disease linked to the reduction of cyclin D3 due to its phosphorylation at Thr283 by active GSK-3β (Figure 6) [20,97]. Here, GSK3B is linked to myotonic dystrophy type 1.